image
Healthcare - Biotechnology - NASDAQ - US
$ 66.29
-6.97 %
$ 11.9 B
Market Cap
-11.84
P/E
BALANCE SHEET
1.33 B ASSETS
-19.72%
1.66 B LIABILITIES
5.95%
-332 M EQUITY
-377.40%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Insmed Incorporated
image
Current Assets 929 M
Cash & Short-Term Investments 780 M
Receivables 41.2 M
Other Current Assets 107 M
Non-Current Assets 401 M
Long-Term Investments 0
PP&E 104 M
Other Non-Current Assets 296 M
Current Liabilities 226 M
Accounts Payable 65.4 M
Short-Term Debt 10.6 M
Other Current Liabilities 150 M
Non-Current Liabilities 1.44 B
Long-Term Debt 1.19 B
Other Non-Current Liabilities 243 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
ASSETS
Cash & Cash Equivalents 482.4 1 074.0 716.8 532.8 487.4 495.1 381.2 162.6 282.9 159.2 113.9 90.8 14.8 10.7 12.7 2.1 16.5 24.1 18.8 9.2 29.5 27.3 51.2 71.6 0.3
Short Term Investments 298.1 74.2 0 0 0 0 0 0 0 0 0 2.2 61.4 97.3 109.4 0.3 0 0 0 0 0 0 0 11.5 4.3
Receivables 41.2 29.7 24.4 16.6 19.2 5.5 0 0 0 0 0 0 0.8 0.5 2.3 0.1 0.2 0.2 0 0 0 0 0 0 0
Inventory 83.2 69.9 67.0 49.6 28.3 7.0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0
Other Current Assets 24.2 25.5 57.8 48.0 40.4 22.7 16.6 11.6 10.5 11.0 2.3 1.3 0.7 0.3 0.2 74 K 0.2 0.5 0.4 0.5 0.2 0.8 3.8 1.5 43.2 K
Total Current Assets 929.1 1 273.4 837.0 622.9 555.2 518.9 389.4 168.4 288.1 164.7 116.2 93.6 77.4 108.8 124.6 2.6 17.0 25.4 19.2 9.7 29.8 28.2 55.0 84.6 4.7
PP&E 104.4 102.1 95.5 97.2 113.1 22.6 12.4 10.0 8.1 7.5 1.8 1.7 1.9 1.1 0 0 4 K 8 K 17 K 27 K 61 K 0.2 1.2 1.6 0.2
Intangible Assets 63.7 68.8 73.8 49.3 53.7 58.7 58.2 58.2 58.2 58.2 58.2 58.2 58.2 0 0 0 0 0 0 0 0 0 0 16.2 0
Goodwill 136.1 136.1 136.1 0 0 0 0 0 0 0 0 0 0 6.3 0 0 0 0 0 0 0 0 15.4 0 0
Long Term Investments 0 0 50.0 0 0 0 0 0 0 0 0 0 2.1 2.2 2.1 0 0.3 0 0 0 0 0 0 0 0
Other Long Term Assets 96.6 76.1 51.0 26.8 20.3 4.3 2.0 1.3 2.1 0.4 0.3 0.1 0.2 77.9 2 K 2.2 2.3 2.9 3.6 3.3 0 0 0 0.2 0.4
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 329.8 1 656.4 1 243.5 796.2 742.3 604.6 462.0 238.0 356.6 230.9 176.5 153.6 139.8 196.3 126.7 4.8 19.5 28.3 22.9 13.0 29.8 28.3 71.6 102.7 5.3
LIABILITIES
Accounts Payable 65.4 50.5 35.8 42.9 13.2 17.7 14.7 10.4 7.5 9.2 5.9 7.1 2.3 1.4 0.3 1.3 0.9 7.2 1.0 2.6 0.7 0.9 4.4 3.4 0.7
Short Term Debt 10.6 8.1 20.3 25.1 24.5 0 0 0 3.1 0 3.3 3.2 0.2 0.2 0.2 1.6 1.3 0 0 0 0 0 0 0 0
Other Current Liabilities 149.6 131.7 79.1 50.8 47.5 62.0 30.0 17.6 11.7 10.4 7.2 5.5 1.9 1.5 1.7 1.5 1.5 2.5 3.9 2.4 2.3 2.6 5.7 0.7 86.9 K
Total Current Liabilities 225.6 190.2 135.2 118.8 85.2 79.7 44.7 28.0 22.3 19.6 16.5 15.7 4.5 3.3 2.8 4.9 3.7 9.7 4.9 5.0 2.9 3.9 10.3 4.1 0.8
Long Term Debt 1 193.4 1 169.7 637.7 428.3 433.6 316.6 55.6 54.8 22.0 24.9 16.3 16.3 0.3 83 K 0 0.5 2.1 3.2 6.4 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 242.8 208.5 60.2 (26.8) (38.2) 0 0.8 0.7 0.6 0.1 0.4 0.6 0.8 0 0 2.2 2.2 1.6 1.0 0.7 0.6 1.0 0 1.8 0
Total Liabilities 1 661.8 1 568.5 833.0 520.3 480.6 396.3 101.0 83.5 44.9 44.6 33.2 32.7 5.6 3.4 2.8 7.6 8.0 14.5 12.3 5.8 3.6 4.9 11.9 5.9 0.8
EQUITY
Common Stock 1.5 1.4 1.2 1.0 0.9 0.8 0.8 0.6 0.6 0.5 0.4 0.3 0.2 1.6 1.3 1.2 1.2 1.0 0.7 0.4 0.4 0.3 0.3 0.3 38.7 K
Retained Earnings (3 446.1) (2 696.6) (2 265.2) (1 830.6) (1 536.5) (1 282.2) (957.9) (765.2) (589.0) (470.8) (391.6) (335.5) (294.2) (234.5) (228.1) (346.4) (330.8) (310.8) (254.7) (213.7) (186.5) (176.2) (139.8) (102.6) (22.8)
Other Accumulative Comprehensive Income/Loss (0.7) 0.8 1.0 0.2 10 K 9 K 3 K 65 K (5.3) (3.3) (3.6) 0 0.5 1.0 0.4 0 (0.2) (0.5) (0.5) (0.5) (0.5) (0.4) (1.2) 0.2 75.4 K
Total Equity (331.9) 88.0 410.5 275.9 261.7 208.3 361.1 154.5 311.7 186.2 143.3 120.9 134.3 192.8 123.9 (2.8) 11.5 13.9 10.5 7.2 26.2 23.4 59.7 96.8 4.5
Total Liabilities and Equity 1 329.8 1 656.4 1 243.5 796.2 742.3 604.6 462.0 238.0 356.6 230.9 176.5 153.6 139.8 196.3 126.7 4.8 19.5 28.3 22.9 13.0 29.8 28.3 71.6 102.7 5.3
SHARES OUTSTANDING
Common Shares Outstanding 140.4 123.0 112.1 97.6 84.6 76.8 66.6 61.9 58.5 43.0 35.0 26.5 23.3 13.2 12.7 12.2 11.5 9.5 4.9 3.9 3.6 3.3 3.3 1.8 0.3